YAP1 and posterior cortical atrophy: Therefore, it is conceivable that treatment of a sub-population of CRPC patients wherein their PCa cells rely partly on YAP1 upregulation and/or Y407 phosphorylation may benefit from a concomitant antiandrogen and J54 combination.